BioSpace News Archive

Headlands Research, a global next-generation clinical research site organization, announced that it has acquired Artemis Institute for Clinical Research.

The next generation Scrambler Therapy® Technology ST-5A has received marketing approval from the FDA.

Natera, Inc., a global leader in cell-free DNA testing, and Personalis, Inc., a leader in advanced genomics for cancer, announced that the two companies have entered into a partnership in the field of personalized oncology.

In the U.S., 50% of adults have high blood pressure, but only one out of four has it under control.1 Preventric Diagnostics is a digital health company that uses its BPro® wearable medical device to capture 24-hour ambulatory blood pressure and is incorporating American Heart Association science-based health management plans, called CarePlans, in its hypertension management platform.

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannabinoid-based medicine, further clarifies with regards to the final study results released on February 16, 2021 ,

PPD, Inc. has been recognized for the 10th consecutive year as one of the leading U.S. businesses for employee learning and development.

FibroGenesis, announced today new data supporting utilizing its fibroblast-based immunotherapy for successful inhibition and induction of regression in preclinical models of breast cancer and pancreatic cancer.

Immunovia has today published its Full Year Report for January - December 2020 . It is available on Immunovia’s website .

Currently, the Company trades on the OTC Pink Sheets under the symbol “MSSTF”.

EpiVax, Inc. announces its participation in the INDIGO consortium – a partnership of public and private research and development organizations from the EU, India, and United States with the aim of developing next-generation influenza vaccines with better responsiveness, lower costs, and better accessibility.